J Angst

发表

J. Angst, J Angst, 1995, European archives of psychiatry and clinical neuroscience.

Pharmacological and Clinical Problems of Lithium Prophylaxis

P. Grof, J. Angst, M. Schou, 1970, British Journal of Psychiatry.

The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders – a life‐long perspective

P. Andersen, L. Kessing, J. Angst, 2004, Acta psychiatrica Scandinavica.

Screening for bipolar disorders: A public health issue.

M. Carta, J. Angst, J Angst, 2016, Journal of affective disorders.

Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders

K R Merikangas, K. Merikangas, H. Qin, 2014, Molecular Psychiatry.

Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis

F. Vollenweider, K. Leenders, J. Angst, 1997, Neuropsychopharmacology.

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.

H. Möller, H. Akiskal, R. Post, 2000, Journal of affective disorders.

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

F. Vollenweider, J. Missimer, K. Leenders, 1997, European Neuropsychopharmacology.

Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.

M. Preisig, J. Angst, M Preisig, 1995, Schweizer Archiv fur Neurologie und Psychiatrie.